
Hepatitis Delta in Focus: Episode 1 of Answering the Questions on Screening, Diagnosis, and Treatment
2023-03-08
0:00
22:43
In this episode, Maria Buti, MD, and Richard H. Davis, PA-C, address key considerations when screening, diagnosing, and treating patients with hepatitis delta virus (HDV), such as:
- Barriers to screening
- HDV screening based on patient risk factors
- Universal screening for all patients with positive hepatitis B surface antigen (HBsAg)
- Reflex testing
- Availability of commercial testing
- Monitoring suggestions in HBsAg positive and HDV antibody positive patients with negative HDV RNA
- Limitations to evaluating advanced fibrosis in patients with HDV
- Data on novel HDV therapies (eg, bulevirtide and lonafarnib)
- Extending HDV therapy (eg, peginterferon) based on treatment response
- Stopping rules (eg, HDV RNA negativity, HBsAg loss) for discontinuing HDV therapy
Faculty:
Maria Buti, MD
Professor of Medicine
Hospital Universitario Vall d’Hebron
Barcelona, Spain
Richard H. Davis, PA-C
Senior PA
Gastroenterology
University of Florida
UF Health
Gainesville, Florida
Link to full program:
http://bit.ly/3yp1Lxf
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Fler avsnitt från "CCO Infectious Disease Podcast"
Missa inte ett avsnitt av “CCO Infectious Disease Podcast” och prenumerera på det i GetPodcast-appen.